A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
| Image |  |
|---|---|
| Description | article by Sven J. van der Lee et al published 27 May 2019 in Acta Neuropathologica |
| Author/s | |
| Publication date | May 27, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |